Emmessar Biotech Share Price | Emmessar Biotech Stock Screener
EMMESSA
Commodity Chemicals
Share Price BSE
₹24.13
▼
-0.27 (-1.11%)
As of July 23, 2026, the Emmessar Biotech share price (BSE: EMMESSA) is ₹24.13, down 1.11% from the previous close, with shares trading between ₹24.13 and ₹24.99, and a 52-week range of ₹19.99–₹39.40.
Analyse Emmessar Biotech stock price data download and track historical price performance.
Use the Emmessar Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Emmessar Biotech Market Cap
₹12.71 Cr.
EMMESSA P/E Ratio (TTM)
27.89
Emmessar Biotech P/B Ratio
1.49
EPS (TTM)
₹0.81
Dividend Yield
-
Debt to Equity
0.01
EMMESSA 52 Week High
₹39.40
Emmessar Biotech 52 Week Low
₹19.99
Operating Margin
-365.00%
Profit Margin
-
EMMESSA Revenue (TTM)
-
EBITDA
₹-1.00
Net Income
-
Total Assets
₹10.00
Total Equity
₹8.00
Emmessar Biotech Share Price Chart
Screen Emmessar Biotech share price with an interactive chart. Analyse EMMESSA price trends and volatility across different timeframes.
Emmessar Biotech Company Profile - Fundamental Screener
Screen Emmessar Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for EMMESSA shares.
Sector
Chemicals
Industry
Commodity Chemicals
Sub-Sector
Commodity Chemicals
Segment
E
ISIN
INE634B01016
Emmessar Biotech Balance Sheet Screener
Screen EMMESSA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 10 | 9 | 9 | 8 | 7 | 8 | 6 | 5 | 4 | 3 |
| Current Assets | 8 | 7 | 7 | 6 | 5 | 5 | 3 | 2 | 1 | 1 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 8 | 8 | 7 | 7 | 6 | 6 | 4 | 4 | 3 | 2 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 3 | 3 | 2 | 2 | 1 | 1 | -1 | -2 | -2 | -3 |
Emmessar Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Emmessar Biotech income statement and profit fundamentals.
Analyze EMMESSA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Emmessar Biotech share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 | 3 | 3 | 2 | 9 | 5 | 2 | 3 | 4 | 2 | 2 |
| Expenses | 2 | 2 | 2 | 2 | 1 | 6 | 4 | 1 | 2 | 2 | 2 | 2 |
| EBITDA | -1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
| Operating Profit % | -365.00% | -156.00% | -195.00% | -68.00% | -245.00% | 12.00% | -12.00% | -102.00% | -32.00% | 9.00% | 1.00% | -7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | -1 | 0 |
| Tax | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -1 | 0 |
| EPS | 0.81 | 0.63 | 1.50 | 0.99 | 0.94 | 2.90 | 1.51 | 1.05 | 1.83 | 2.36 | -0.93 | -0.24 |
Emmessar Biotech Cash Flow Screener - Liquidity Fundamentals
Screen EMMESSA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 1 | 0 | 2 | 1 | 1 | 0 | 1 | 1 | 0 |
| Investing Activities | 0 | -1 | -1 | -3 | 0 | -1 | 0 | -1 | -1 | -1 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Emmessar Biotech Shareholding Pattern Screener
See Emmessar Biotech shareholding pattern with promoter, FII, and DII holdings.
Check Emmessar Biotech promoter holding and ownership changes for EMMESSA on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% | 59.53% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% | 0.20% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.07% | 38.07% | 37.15% | 37.14% | 38.12% | 38.09% | 37.94% | 37.64% |
| Other Holding | 2.21% | 2.21% | 3.12% | 3.14% | 2.16% | 2.19% | 2.33% | 2.64% |
| Shareholder Count | 7,172 | 7,136 | 7,180 | 7,173 | 7,350 | 7,244 | 7,146 | 6,900 |
Emmessar Biotech Share Dividend Screener - Share Yield Analysis
Check Emmessar Biotech dividend history with payout and yield data.
View Emmessar Biotech dividend details including ex-dates and amounts for EMMESSA stock.
Emmessar Biotech Stock Index Membership
See which indices include Emmessar Biotech stock.
Check EMMESSA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Emmessar Biotech Market Events Screener - Corporate Actions
Get Emmessar Biotech corporate actions including splits, bonuses, and buybacks.
Check Emmessar Biotech stock events that may affect EMMESSA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-12 | 2026-05-12 | Quarterly Result Announcement | NA | 2.94% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 2.14% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.36% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | 23.37% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -4.34% |
| 2025-04-24 | 2025-04-24 | Quarterly Result Announcement | NA | 6.06% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 7.24% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 43.67% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 7.42% |
Emmessar Biotech Competitors Screener - Peer Comparison
Screen EMMESSA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Deepak Fertilisers & Petrochemicals | 20,262 | 27.29 | 11,506 | 11.11% | 725 | 57.58 |
| Tata Chemicals | 17,670 | -10.37 | 14,900 | -1.40% | -1,715 | 42.28 |
| Gujarat Narmada Valley Fert & Chem | 7,444 | 9.14 | 7,773 | -7.39% | 753 | 43.89 |
| TANFAC Industries | 5,758 | 81.17 | 711 | 27.00% | 73 | 76.36 |
| Gujarat Alkalies & Chemicals | 4,450 | -1778.94 | 4,358 | 4.64% | 20 | 37.38 |
| GHCL | 4,003 | 8.45 | 3,138 | -4.08% | 473 | 46.59 |
| Grauer & Weil | 3,428 | 21.54 | 1,190 | 0.86% | 168 | 51.86 |
| Chemplast Sanmar | 3,188 | -11.05 | 4,252 | -3.21% | -280 | 40.22 |
| Fischer Medical Ventures | 2,589 | 83.85 | 309 | 175.03% | 30 | 58.00 |
| Thirumalai Chemicals | 1,958 | -11.83 | 1,754 | -15.26% | -168 | 42.24 |
Emmessar Biotech Company Announcements - News Screener
Screen EMMESSA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-14 | Newspaper Add On Relodgement Of Shares | - |
| 2026-05-13 | Newspaper Add For Financial Results For The Period Ended March 31 2026 | - |
| 2026-05-12 | Results For Perid Ended 31.03.2026 | - |
| 2026-05-12 | Board Meeting Outcome for Audited Financial Results For Period Ended March 31 2026 | - |
| 2026-05-05 | Board Meeting Intimation for Approval Of Audited Results For Quarter And Year Ended March 31 2026 | - |
| 2026-04-08 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-10 | Newspaper Add For Re-Lodgement Of Transfer Requests Of Physical Shares Under Special Window | - |
| 2026-02-12 | Newspaper Add | - |
| 2026-02-11 | Results- Financial For 31-12-2025 | - |
| 2026-02-11 | Board Meeting Outcome for For Unaudited Results For December 31 2025 | - |
| 2026-02-04 | Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended December 31 2025. | - |
| 2026-01-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-24 | Closure of Trading Window | - |
| 2025-11-13 | Newspaper Add | - |
| 2025-11-12 | Results For Quarter Ended September 30 2025 | - |
| 2025-11-12 | Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended Sept 30 2025 | - |